Logo des Robert Koch-InstitutLogo des Robert Koch-Institut
Publikationsserver des Robert Koch-Institutsedoc
de|en
Publikation anzeigen 
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
JavaScript is disabled for your browser. Some features of this site may not work without it.
Gesamter edoc-ServerBereiche & SammlungenTitelAutorSchlagwortDiese SammlungTitelAutorSchlagwort
PublizierenEinloggenRegistrierenHilfe
StatistikNutzungsstatistik
Gesamter edoc-ServerBereiche & SammlungenTitelAutorSchlagwortDiese SammlungTitelAutorSchlagwort
PublizierenEinloggenRegistrierenHilfe
StatistikNutzungsstatistik
Publikation anzeigen 
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
2005-08-24Zeitschriftenartikel DOI: 10.1002/jmv.20441
Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey.
Chmielewicz, Barbara
Benzler, Justus
Pauli, Georg
Krause, Gérard
Bergmann, Frank
Schweiger, Brunhilde
In April 2004, two patients were admitted to hospital in Berlin, Germany, with clinical signs of acute respiratory infection after returning from a military exercise in their home country of Turkey. They were admitted to a high security infectious disease unit as epidemiological data pointed to an outbreak of unknown etiology. Samples taken at the time of admission proved to be strongly positive for Adenovirus by PCR, but negative for Influenza A/H1N1 virus, Influenza A/H3N2 virus, Influenza B virus, Respiratory syncytial virus, and SARS coronavirus. No evidence for bacterial infection was obtained by serological tests and blood cultures. The adenovirus detected was characterized further by genotyping and was identified as a species B2 virus with the highest similarity to adenovirus type 11a.
Dateien zu dieser Publikation
Thumbnail
29SVgkUwWKrc.pdf — PDF — 85.40 Kb
MD5: 75fd398f09f6708c609d3bb588174048
Zitieren
BibTeX
EndNote
RIS
Keine Lizenzangabe
Zur Langanzeige

Verwandte Publikationen

Anzeige der Publikationen mit ähnlichem Titel, Autor, Urheber und Thema.

  • 2016-09-16Zeitschriftenartikel
    Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation 
    Voigt, Sebastian; Hofmann, Jörg; Edelmann, Anke; Sauerbrei, Andreas; Kühl, J. S.
    Infections with adenovirus (AdV) and herpesviruses can result in considerable morbidity and mortality in pediatric hematopoietic stem cell transplant (SCT) recipients. Herpes simplex virus (HSV) reactivations are usually ...
  • 2015-08-13Zeitschriftenartikel
    Age-related prevalence of cross-reactive antibodies against influenza A(H3N2) variant virus, Germany, 2003 to 2010 
    Blümel, Benjamin; Schweiger, Brunhilde; Dehnert, Manuel; Buda, Silke; Reuss, Annicka; Czogiel, Irina; Kamtsiuris, Panagiotis; Schlaud, Martin; Poethko-Müller, Christina; Thamm, Michael; Haas, Walter
    To estimate susceptibility to the swine-origin influenza A(H3N2) variant virus (A(H3N2)v) in the German population, we investigated cross-reactive antibodies against this virus and factors associated with seroprotective ...
  • 2011-07-18Zeitschriftenartikel
    Effectiveness of the AS03-Adjuvanted Vaccine against Pandemic Influenza Virus A/(H1N1) 2009 - A Comparison of Two Methods; Germany, 2009/10. 
    Uphoff, Helmut; Heiden, Matthias an der; Schweiger, Brunhilde; Campe, Hartmut; Beier, Dietmar; Helmeke, Carina; Littmann, Martina; Haas, Walter; Buda, Silke; Faensen, Daniel; Feig, Marcel; Altmann, Doris; Wichmann, Ole; Eckmanns, Tim; Buchholz, Udo
    During the autumn wave of the pandemic influenza virus A/(H1N1) 2009 (pIV) the German population was offered an AS03- adjuvanted vaccine. The authors compared results of two methods calculating the effectiveness of the ...
Nutzungsbedingungen Impressum Leitlinien Datenschutzerklärung Kontakt

Das Robert Koch-Institut ist ein Bundesinstitut im

Geschäftsbereich des Bundesministeriums für Gesundheit

© Robert Koch Institut

Alle Rechte vorbehalten, soweit nicht ausdrücklich anders vermerkt.

 
DOI
10.1002/jmv.20441
Permanent URL
https://doi.org/10.1002/jmv.20441
HTML
<a href="https://doi.org/10.1002/jmv.20441">https://doi.org/10.1002/jmv.20441</a>